Cita APA

Hu, Y., Zhang, X., Zai, H., Jiang, W., Xiao, L., & Zhu, Q. (2020). lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1. Mol Ther Oncolytics.

Chicago Style Citation

Hu, Yu, Xian Zhang, Hong-Yan Zai, Wei Jiang, Liang Xiao, i Qin Zhu. "LncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC Via Upregulating FOXM1." Mol Ther Oncolytics 2020.

Cita MLA

Hu, Yu, et al. "LncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC Via Upregulating FOXM1." Mol Ther Oncolytics 2020.